1u2y: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
A new approach for the discovery and subsequent structural elucidation of, oligosaccharide-based inhibitors of alpha-amylases based upon, autoglucosylation of known alpha-glucosidase inhibitors is presented. This, concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of, human pancreatic alpha-amylase with a K(i) value of 18 mm to a, trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional, structure of this complex was determined by x-ray crystallography and, represents the first such structure determined with this class of, inhibitors in any alpha-glycosidase. This approach to the discovery and, structural analysis of amylase inhibitors should be generally applicable, to other endoglucosidases and readily adaptable to a high throughput, format.
A new approach for the discovery and subsequent structural elucidation of oligosaccharide-based inhibitors of alpha-amylases based upon autoglucosylation of known alpha-glucosidase inhibitors is presented. This concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of human pancreatic alpha-amylase with a K(i) value of 18 mm to a trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional structure of this complex was determined by x-ray crystallography and represents the first such structure determined with this class of inhibitors in any alpha-glycosidase. This approach to the discovery and structural analysis of amylase inhibitors should be generally applicable to other endoglucosidases and readily adaptable to a high throughput format.


==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Begum, A.]]
[[Category: Begum, A.]]
[[Category: Brayer, G.D.]]
[[Category: Brayer, G D.]]
[[Category: Damager, I.]]
[[Category: Damager, I.]]
[[Category: Li, C.]]
[[Category: Li, C.]]
[[Category: Numao, S.]]
[[Category: Numao, S.]]
[[Category: Overall, C.M.]]
[[Category: Overall, C M.]]
[[Category: Withers, S.G.]]
[[Category: Withers, S G.]]
[[Category: Wrodnigg, T.M.]]
[[Category: Wrodnigg, T M.]]
[[Category: CA]]
[[Category: CA]]
[[Category: CL]]
[[Category: CL]]
Line 33: Line 33:
[[Category: inhibitor]]
[[Category: inhibitor]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:59:06 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:20:20 2008''